Writing in December 2021, Liz Crowe reflects on what the loss of physical touch during COVID-19 meant for patients, staff and families. She explores touch, wellbeing and ways to preserve compassion and connection when infection precautions limit contact.
To Touch or not to Touch that is the Question. Touch and COVID19 Read More
An August 2021 appraisal of therapeutic-dose heparin in hospitalised COVID-19 patients without ICU-level organ support. It examines the multiplatform trial’s benefits, bleeding-risk exclusions and composite outcome, and explains why these findings differ from those in critically ill patients.
JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s Read More
A June 2021 review of early RECOVERY results for casirivimab and imdevimab in hospitalised COVID-19 patients. It explains the reported mortality benefit in patients without detectable antibodies, why that finding did not extend to the whole trial population, and the preliminary evidence available then.
REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s Read More
A June 2021 look at the first RECOVERY results for aspirin in hospitalised COVID-19 patients. The review considers the absence of a demonstrated mortality benefit, the balance between bleeding and thrombotic events, and the limits of the early results.
JC: Aspirin is not effective for hospitalised COVID19 patients. St Emlyn’s Read More
Iain and Simon’s March 2021 round-up covers RECOVERY results, trauma triage, cricothyroidotomy and COVID-19 thromboprophylaxis. The episode also discusses emerging concerns about vaccine-induced thrombosis, alongside the FRCEM revision guide and changes to undergraduate medical education.
Podcast – March 2021 Monthly Round Up Read More
An April 2021 discussion of post-vaccination headache as evidence about vaccine-induced thrombosis and thrombocytopenia was emerging. It explores VITT, cerebral venous sinus thrombosis and the role of clinical probability, targeted investigation and specialist input, reflecting the uncertainties and guidance available at that time.
Post-vaccine headache in the Emergency Department: what you need to know. St Emlyn’s Read More
A March 2021 appraisal of anticoagulation trials in critically ill patients with COVID-19. Simon Carley and Dan Horner examine therapeutic-dose versus usual-care thromboprophylaxis, organ support outcomes and bleeding, explaining why the findings cannot simply be extended to ward patients or treatment of confirmed thrombosis.
JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s Read More
Iain and Simon revisit February 2021 on the St Emlyn’s blog and podcast. The accompanying article links cover TIA risk assessment, proposed emergency care standards, tocilizumab evidence, TXA for epistaxis and conversations with patients about COVID-19 risk.
Podcast – February 2021 Monthly Round Up Read More
